MENU
+Compare
BCYC
Stock ticker: NASDAQ
AS OF
Oct 14 closing price
Price
$7.90
Change
-$0.22 (-2.71%)
Capitalization
546.14M

BCYC Bicycle Therapeutics plc Forecast, Technical & Fundamental Analysis

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BCYC with price predictions
Oct 14, 2025

BCYC saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for BCYC moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 53 similar instances where the indicator exited the overbought zone. In of the 53 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BCYC moved out of overbought territory on October 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCYC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BCYC broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on BCYC as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

BCYC moved above its 50-day moving average on September 29, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BCYC crossed bullishly above the 50-day moving average on October 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BCYC advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 157 cases where BCYC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.816) is normal, around the industry mean (24.376). P/E Ratio (0.000) is within average values for comparable stocks, (54.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.175). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (28.249) is also within normal values, averaging (341.418).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BCYC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCYC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BCYC is expected to report earnings to fall 6.14% to -107 cents per share on October 30

Bicycle Therapeutics plc BCYC Stock Earnings Reports
Q3'25
Est.
$-1.07
Q2'25
Missed
by $0.20
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.06
The last earnings report on August 08 showed earnings per share of -113 cents, missing the estimate of -93 cents. With 221.83K shares outstanding, the current market capitalization sits at 546.14M.
A.I. Advisor
published General Information

General Information

a holding company, which engages in the development of biopharmaceuticals.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAGCX53.66N/A
N/A
Carillon Eagle Mid Cap Growth C
GOCAX15.13N/A
N/A
Gabelli International Small Cap A
NWKCX80.43N/A
N/A
Nationwide Geneva Small Cap Gr R6
LFGFX43.71N/A
N/A
Lord Abbett Focused Growth F
ARRQX22.67N/A
N/A
Aristotle Value Equity R6

BCYC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.96%
RPTX - BCYC
54%
Loosely correlated
+3.30%
ATXS - BCYC
43%
Loosely correlated
+37.66%
RGNX - BCYC
43%
Loosely correlated
-0.71%
XNCR - BCYC
43%
Loosely correlated
-11.03%
AUTL - BCYC
42%
Loosely correlated
-2.42%
More